0000899243-23-003629.txt : 20230202
0000899243-23-003629.hdr.sgml : 20230202
20230202183809
ACCESSION NUMBER: 0000899243-23-003629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230131
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foster Wayne
CENTRAL INDEX KEY: 0001709769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 23582869
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-31
0
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001709769
Foster Wayne
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
0
1
0
0
EVP, Chief Accounting Officer
Restricted Stock Units
2023-01-31
4
A
0
100000
0.00
A
Common Stock
100000
100000
D
Stock Option (Right to Buy)
4.63
2023-01-31
4
A
0
140000
0.00
A
2033-01-30
Common Stock
140000
140000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.
/s/ Andrea Corcoran, as Attorney-in-Fact for Wayne Foster
2023-02-02